Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Cowden Syndrome
NCT04094675Phase 2Completed
- Sponsor
- The Ohio State University
- Start
- Sep 2019
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in Cowden syndrome (CS), sponsored by The Ohio State University. Primary endpoints: Change in colon polyp burden by number at 1 year and Change in colon polyp burden by staging at 1 year. Started Sep 2019; status: completed.
02
Drugs
sirolimus
03
Conditions
Cowden syndrome (CS)
Beyond the preview
Go deeper on NCT04094675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094675.